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The purpose of this study is to compare left ventricular ejection fraction
(LVEF) and regional wall motion (RWM) during exercise to LVEF and RWM
during dobutamine infusion in the same pts. Ten pts (8 males, 2 females,
mean age 56.9 ± 11,1), with known or suspected coronary disease, who
had abnormal symptom-limited upright bicycle exercise first-pass radionu-
c1ide angiograms (FPRNA). had dobutamine FPRNA within 3 months of the
exercise study and prior to any intervention or interim cardiac event. Dobu-
tamine was given incrementally up to 40 ILglkg/min. Atropine was given to
increase heart rate as needed. FPRNA was performed by injecting 25 mCi of
Tc-99m-sestamibi at the peak dobutamine dose.
Stress-Rest Dobutamine SPECT Tc-99m
Sestamibi Accurately Predicts Myocardial
Viability in Dysynergic Left Ventricular
Segments
Myocardial Rb Extraction Fraction:
Determination In Humans
Positron Emission Tomography
HR x SBP LVEF EDV ESV RWMA REF
Exercise
33,100 ± 4,882 61 ±62 182 ± 56 76 ± 32 10 ± 10 46 ± 6.8
Dobutamine
24,669 ± 5,571 72 ± 5.5 135 ± 44 43 ± 20 3 ± 10 67 ± 8.8
'p ~ < 0.0001 (Ttest). "p ~ 0.05ITtestl, "'p = 0.005 (chi-squarel
EDV ~ end diastolic volume, ESV ~ end systolic volume, RWMA ~ regional wall motion
abnormality, REF ~ regional ejection fraction of abnormal segments, SBP ~ systolic blood
pressure, HR = heart rate
Roxy Senior, Usha Raval, Sumit Basu, Avijit LahirL Northwick Park Hospital, Harrow,
UK
There has been increasing controversy regarding the ability of SPECT Tc-
99m Sestamibi (MIBI) for identification of myocardial viability in regions of
the left ventricle affected by severe wall motion abnormality, We have evalu-
ated 27 patients with documented coronary artery disease (CAD) and severe
regional wall motion abnormality of the left ventricle due to CAD. All patients
underwent low dose (5-10 ILg/kg) dobutamine echocardiography and maxi-
mal (15-40 ILglkg/min) stress dobutamine MIB!. A separate day SPECT MIBI
was performed at rest. The left ventricle was divided into 3 regions; a total of
37 regions were found to have severe wall motion abnormality by echocar-
diography, of which 35 showed improved wall thickening with low dose
dobutamine (gold standard for myocardial viability in this study). Rest MIBI
uptake was assessed semiquantitatively for each of the matching regions,
and this was graded from 1 to 4, from normal to absent perfusion. Regions
with myocardial perfusion of a grade of 3 or less were considered viable by
rest MIB!. Rest MIBI detected viability in 32 (93%) of the viable regions, as
defined by echocardiography, the concordance was 92% (kappa = 0.54, P
< 0.001). Furthermore, stress-rest MIBI revealed completely reversible de-
fects in 18 (23%), partially reversible defects in 24 (69%) and Grade 4 uptake
and fixed (non-viable) defects in 3 (8%) regions defined as viable by dobu-
tamine echocardiography. Thus, rest MIBI is a good indicator of myocardial
viability in left ventricular segments showing severe regional dysynergy, and
reversible ischaemia detected by stress-rest dobutamine MIBI in these seg-
ments provides further proof that sestamibi SPECT accurately defines re-
gional myocardial viability.
Exercise and dobutamine regional and global LV function are not compa-
rable diagnostically or prognostically. Dobutamine LV function is not a surro-
gate for exercise LV function.
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Ouantitation of myocardial blood flow (MBF) with diffusion-limited radiotrac-
ers as 82Rb and positron emission tomography (PET) requires knowledge of
flow dependence of myocardial 82Rb extraction fraction. To determine this
dependence we evaluated 7 patients (mean age (61.0 ± 9,7) years, 4 males,
3 females) who had undergone coronary angiography with exclusion of rele-
vant coronary stenoses and normal left ventricular function. 82 Rb-PET clear-
ance was simUltaneously assessed with global MBF by the argon (Ar) inert
gas method. 82Rb clearance was dynamically measured by a CTI-Siemens
ECAT 931-08-12 scanner after Lv, injection of 1-1.2 GBq 82Rb. Ar gas de-
saturation was obtained by simultaneous arterial and coronary sinus blood
sampling. Measurements were performed at rest and during vasodilatation
induced by Lv. dipyridamole (0,7 mg/kg/4 mini. Mean 82Rb clearance and Ar
flow values were (0.39 ± 0,03) ml/g/min and (0.69 ± 0.14) ml/g/min at rest.
respectively, and (0.47 ± 0.09) ml/g/min and (1.48 ± 0.49) ml/g/min during
hyperemia. A fit with a two compartment model yielded E = PS/(PS + MBF)
with PS = (0.82 ± 0.09) ml/g/min (PS: permeability surface area product).
These data (figure) provide for the best of our knowledge the first measured
82Rb extraction fraction in humans and may form the basis for more accurate
quantitation of myocardial blood flow with 82Rb-PET.
11011-1161
Comparison of Arbutamine Stress and
Treadmill Exercise Thallium-201 SPECT:
Hemodynamics and Diagnostic Accuracy
Is a Dobutamine Infusion a Legitimate
Alternative to Exercise?
Hasen Kiat, Daniel S. Berman, International Arbutamine Study Group. Cedars Sinai
Medical Center, Los Angeles
Arbutamine (ARB). a new tJ-agonist developed as a pharmacologic stress
agent, was compared with treadmill exercise testing (Ex) in a multicenter
study using thallium-201 (Til SPECT A total of 75 patients (pts) performed
both forms of stress. Of the 73 pts having quantitative angiography, 68
(93%) had coronary artery disease (:::50% stenosis). TI scans were obtained
in 68 pts and were scored by a central laboratory using a twenty segment
(seg)/scan visual analysis (5 point system: 0 = normal, 4 = absent uptake;
segmental score :::2 = defect). Stress TI segs with defects were further clas-
sified as reversible (rev) or nonreversible (nonrev). Hemodynamic response
was summarized for 75 pts. Maximum heart rate (HR) by ARB and Ex was
122 vs 141 bpm, respectively (p < 0,05); mean %HR change from baseline
was similar (79% vs 82%, respectively). Maximum systolic BP for ARB and
Ex was 173 vs 176 mmHg, respectively and mean %change from baseline
was 31 % vs 26%, respectively (p = NS for bothl. In the 68 pts with angio-
graphic CAD, sensitivity for detecting CAD by ARB TI was 94% and 97% by
Ex TI-SPECT (p = NS). Stress TI-SPECT segmental agreement for presence
or absence of defect between ARB and Ex in 1360 segs (68 pts) was 94%
(k = 0.7). Of 76 discordant segs, 38 (50%) were normal by ARB and abnor-
mal by Ex. Exact segmental stress TI score (0-4) agreement was 85% (k =
0.7). Of the 199 segs with discordant scores, the ARB-TI score was higher
in 98 (49%), Among 346 segs with stress defects by both ARB and Ex, de-
fect rev agreement was 86% (k = 0.7). Of the 50 discordant segs, 25 (50%)
were rev by ARB and nonrev by Ex. Adverse events were mostly mild. Sus-
tained arrhythmias were not observed; 3 pts had nonsustained ventricular
tachycardia with ARB and 1 with Ex.
Conclusion: In this patient population, arbutamine and treadmill exercise
produced a similar degree of hemodynamic response compared to baseline.
The two forms of stress yielded similar diagnostic accuracy and high agree-
ment for the presence, extent, severity and reversibility of stress myocardial
perfusion abnormalities.
(Medtronic or CPI). were obtained in 29 patients undergoing routine exer-
cise or dipyridamole TI-201 stress testing. Patches were positioned over the
anterior, mid, or posterior axillary line in the fourth intercostal space. Gated
planar TI-201 images with and without patches were used to determine the
presence of preserved regional wall motion in the area of the patch-induced
attenuation defect. Readers were blinded to the patch type, location, and
order of imaging, which were all randomized. Two independent readers: (1)
inspected the 2 sets of the 32 raw images from the 1800 acquisition to deter-
mine if the patch was visible, (2) interpreted 2 sets of tomograms for defects,
and (3) assessed regional wall motion in the area of the defect. Results: Patch
location could be identified in 42% of patients with CPI patches and 71 %
with Medtronic patches. Attenuation defects were observed in 6 patients
(35%) with Medtronic patches and 4 patients (33%) with CPI patches. In the
subset of patients with patch-induced defects, preserved wall motion was
present in 89% of these regions. Conclusions: Subcutaneous patches can
cause attenuation defects which may be mistaken as an area of infarction.
Normal wall motion on gated images allows differentiation between attenu-
ation artifacts due to the patches from fixed defects due to infarction.
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Necrotic areas showed the largest reduction in baseline MBF. Dyssyner-
gic viable regions showed a reduced resting MBF, but maintained a residual
perfusion reserve in response to inotropic stimulation. Thus, Nisoldipine se-
lectively improved basal perfusion in dysynergic viable myocardium.
'p < 0.05vs Normal, @p < 0.05vs Viable, 'p < 005 vo relative Basal. 'p < 0.05 vo Basal
before Nisoldipine
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Claudio Brunelli, Oberdan Parodi, Gianmario Sambuceti, Luca Corsiglia, Gian
M. Rosa, Assuero Giorgetti, Gian P Bezante, Nicola Nista, Salvatore Caponnetto.
Dept of Cardiology University of Genova, Italy; CNR Institute of Clinical Physiology, Pisa,
Italy
After infarction, regional dysfunction can occur in still viable myocardial re-
gions because of the presence of baseline hypoperfusion. Recent evidence
suggests that these areas may maintain a residual perfusion reserve. Aim of
this study was to evaluate whether oral Nisoldipine can increase regional my-
ocardial myocardial blood flow (MBF) in dyssynergic but viable myocardium
after myocardial infarction. To this purpose, 15 patients with isolated left
anterior descending coronary (LAD) stenosis were studied 1 month after
first myocardial infarction. Patients underwent F18-deoxiglucose imaging,
while MBF was measured, using positron emission tomography and 13N-
Ammonia, at baseline and following dobutamine (10 Ilcglkg/min over 5 min-
utes, DOB). MBF measurements were repeated 24 hours later after Nisoldip-
ine (10 mg bid). Among atotal of 102 LAD related regions, 23 showed normal
wall motion at 2D-echo and normal metabolic activity INormal), 58 showed
wall motion abnormality and preserved deoxiglucose uptake (Viable), while
21 dyssynergic regions were necrotic (Necrotic). MBF data (mllmmf1 00 g)
were as follows:
flow inhomogeneity (CD/control flow ratio: 0.58 ± 0.10 vs 0.81 ± 0.22, re-
spectively, p ± 0.02). Despite so different coronary anatomy (one vessel oc-
cluded the other normal), a linear, direct correlation was observed between
flow reserve of CD and remote regions (r = 0.83, P < 0.01). Thus, despite
resting hypoperfusion, CD maintains a residual perfusion reserve that can
be almo~t fUlly utilized during moderate increases in oxygen consumption.
A global microvascular disorder affects the adaptation to chronic coronary
occlusion.
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Effect of Nisoldipine on Hypoperfused
Dyssynergic Viable Myocardium After
Myocardial Infarction
Keith L. March, Soonpin Yei, Julia Madison, Bruce C. Trapnell. Krannert InsMute of
Cardiology and RL Roudebush VAMC, Indpls, IN; Genetic Therapy, Inc., Gaithersburg,
MD
Gene transfer to the vascular wall utilizing locally-delivered recombinant ade-
noviral vectors has shown promise as a novel technique for therapeutic as
well as experimental modulation of vascular wall gene expression. Infusion
of such vectors using porous balloon catheters WBC) has previously been
demonstrated to result in transduction of extravascular cells at the deliv-
ery site, as well as substantial systemic transduction as a consequence
of release of vector into the circulation. Introduction of a vascular-directed
promoter into the adenoviral vector should thus contribute to targeting the
expression of genes to the vascular wall, while reducing peri-vascular and
systemic expression. In order to test the feasibility of utilizing the vascu-
lar smooth muscle a-actin (SMA) promoter to confer tissue specificity upon
a recombinant adenoviral vector, we constructed an adenovirus (AvLacZ5)
employing a 1.1 kilobase region of the murine SMA promoter to direct the
expression of the nuclear-targeted beta-galactosidase (lacZ) gene and eval-
uated gene transduction by this vector, in comparison with a vector differing
only by the presence of the RSV-LTR promoter. Several cell types were used
as targets, including bovine aortic smooth muscle cells (BASMCl. human
pulmonary epithelial carcinoma cells (A549 cells), and transformed human
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Comparison of 82Rubidium Positron Emission
Tomography to 99Technetium-Methoxyisobutyl
Isonitrile Perfusion Imaging
Blood Flow Regulation in Collateral Dependent
Myocardium
lACC February 1995
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This study was designed to prospectively compare myocardial perfusion
imaging with rubidium-82 (B2Rb) by positron emission tomography (PET) to
technetium-99m - methoxyisobutyl isonitrile (MIBI) by single photon emis-
sion computed tomography (SPECT). Detection of inducible ischemia and
prior infarction was assessed in 53 patients (pts) with known coronary artery
disease (CAD) who had undergone quantitative coronary angiography. To
assign independently myocardial viability both techniques were compared
to resting, glucose loaded myocardial uptake of fluorine-18 fluorodeoxyglu-
cose (FOG) PET in a subgroup of 27 pts. with left ventricular wall motion ab-
normalities. Intravenous dipyridamole vasodilatation (0.7 mglkg) was used
as myocardial stress modality, with B2Rb and MIBI being injected simulta-
neously under identical hemodynamic conditions. SPECT and PET results
were scored in a 13 segment model of the left ventricle as normal. inducible
ischemia, infarction or infarction with adjacent ischemia. There were con-
cordant findings in 48 out of 53 analysed pts. (91 %). However, in 5 pts.
(9%) MIBI-SPECT showed fixed perfusion defects but ischemia by B2Rb-PET
and evidence of viable myocardium with FOG-PET. whereas there was no
segment with infarction in B2Rb-PET and ischemia in SPECT. We conclude
that MIBI-SPECT detects less inducible ischemia but more fixed perfusion
defects compared to B2Rb-PET in the same patient population. Sensitivity
of stresslrest B2 Rb-PET in detection of 2:70% stenosed vessel was 33/33
(100%) in LAD territory respectively 31/32 (97%) in LCx/RCA territory with
specificity of 93%. MIBI SPECT sensitivity in the same group was 29/33
(88%) for LAD and 31/32 (97%) for LCx/RCA territory with specificity of 90%
in LAD territory respectively 71 % in LCx/RCA. These data strongly suggest
that MIBI-SPECT underestimates the presence of ischemic and still viable
myocardium in comparison to B2Rb_ and FOG-PET. In contrast myocardial vi-
ability as assessed by B2 Rb- and FOG-PET correlated well. Thus stress/rest
B2Rb-PET holds promise for reliable assessment of reversible ischemia and
myocardial Viability.
Klaus P Bergmann, Gerhard Glatting, Brigitte Grab, Matthias Hess, Heinz Breuer 1,
Matthias Kochs 1, Vinzenz Hombach 1, Sven N. Reske. Department ofNuclear
Medicine, University of VIm, Germany; 1 Medical Clinic, University of VIm, Germany
Gianmario Sambuceti, Oberdan Parodi, Assuero Giorgetti, Paolo Marzullo,
Alessandro Riva, Nicola Nista, Antonio L:Abbate. CNR Institute of Clinical Physiology,
Pisa, Italy
Myocardial blood flow (MBF) regulation in collateral dependent myocardium
(CD) of patients with coronary artery disease has not been fUlly elucidated.
To this purpose, 19 patients with stable angina, no previous myocardial in-
farction and isolated occlusion of the left anterior descending (n = 14) or
left circumflex (n = 5) coronary artery were evaluated. MBF measurements
were obtained off-therapy, using dynamic positron emission tomography and
nitrogen-13 Ammonia, at baseline, during atrial pacing tachycardia and after
i.v. dipyridamole (0.56 mg/l:g over 4 min). MBF in CD and remote regions
were compared with MBF values Obtained in 13 normal subjects. At rest.
MBF was similar in CD and in the remote myocardium (0.61 ± 0.11 vs 0.63
± 0.17 mllmin/gl. both values were lower than normal (1.00 ± 0.2 ml/min/g,
p < 0.01). During pacing MBF increased to 0.84 ± 0.25 and 1.11 ± 0.39
ml/min/g in CD and contralateral areas, respectively (p < 0.05 vs baseline);
both these values were lower (p < 0.01) than normal (1.86 ± 0.61 mllmin/g).
Dipyridamole induced a further increase in MBF in remote areas (1.36 ± 0.57
mllmin/g, p < 0.01 vs pacing) but not in CD (0.93 ± 0.37 mllmin/g, ns vs pac-
ing); both values were reduced (p < 0.01) with respect to normals (3.46 ±
0.78 mllmin/g). Dipyridamole MBF in CD was slightly lower in patients with
poor than in those with well developed cOllaterals (0.75 ± 0.29 vs 1.06 ±
0.38 ml/min/g, respectively, p = 0.06). however, the former showed a higher
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